CAR T cells targeting CD19 inhibited the production of autoantibodies, ameliorated disease symptoms in affected organs, and significantly prolonged survival beyond typical lifespans in the (NZB × NZW) F1 and MRL fas/fas murine models of lupus. This evidence concerns the gene CD19 and systemic lupus erythematosus.